• Mashup Score: 0

    Objective The Lupus Foundation of America Rapid Evaluation of Activity in Lupus (LFA-REAL) system is a novel and simple SLE disease activity instrument, consisting of a tandem clinician-reported (ClinRO) and patient-reported (PRO) outcome measure. The aim of this study was to compare the LFA-REAL system with other SLE activity measures in the phase III trial of ustekinumab in patients with active SLE. Methods This was a prespecified analysis of data from a randomised, double-blind, placebo-controlled, parallel-group trial conducted at 140 sites in 20 countries. Correlations were evaluated between the LFA-REAL ClinRO and PRO with a panel of clinician-reported and patient-reported disease activity measures commonly used in SLE clinical trials at baseline, week 24 and week 52. All p values are reported as nominal. Results Trial participants included 516 patients with SLE with a mean (SD) age of 43.5 (8.9), of whom 482 (93.4%) were female. The LFA-REAL ClinRO correlated with Physician Glob

    Tweet Tweets with this article
    • Interested to #learn more from the new #podcast ? The following article provides #data from this #study support further #development of the #LFA-REAL #SLE #lupus #autoimmunity #rheumatology https://t.co/LQDl3Dhegy

  • Mashup Score: 0

    The importance of big health data is recognised worldwide. Most UK National Health Service (NHS) care interactions are recorded in electronic health records, resulting in an unmatched potential for population-level datasets. However, policy reviews have highlighted challenges from a complex data-sharing landscape relating to transparency, privacy, and analysis capabilities. In response, we used public information sources to map all electronic patient data flows across England, from providers to more than 460 subsequent academic, commercial, and public data consumers.

    Tweet Tweets with this article
    • NEW Health Policy: 'Mapping and evaluating national #data flows: transparency, privacy, and guiding infrastructural transformation'. https://t.co/binwtA5S3e https://t.co/HuuQ3pELBl